Comprehensive and up to date, the third edition of Diagnostic Pathology: Kidney Diseases, written by Robert B. Colvin, MD and Anthony Chang, MD, expertly covers all aspects of common and rare renal diseases and their variants. This easy-to-use, point-of-care reference offers a state-of-the-art, concise presentation of major pathological, clinical, pathophysiological, and genetic information for more than 240 diagnoses, making it an ideal resource for pathologists and nephrologists to improve knowledge and skills. Significantly revised information throughout ensures that you remain current with everything new regarding the pathology and pathogenesis of nonneoplastic kidney diseases.
1. SECTION 1: INTRODUCTION AND OVERVIEW - p. xxiv 2. Chapter 1: Introduction to Renal Pathology - p. xxiv 3. Chapter 2: Normal Kidney Structure - p. 23 4. Chapter 3: Normal Kidney Development - p. 35 5. SECTION 2: GLOMERULAR DISEASES - p. 45 6. PODOCYTOPATHIES - p. 45 7. Chapter 4: Minimal Change Disease - p. 45 8. Chapter 5: Classification of Focal Segmental Glomerulosclerosis - p. 55 9. Chapter 6: Etiologies of Focal Segmental Glomerulosclerosis - p. 59 10. Chapter 7: Focal Segmental Glomerulosclerosis, Primary - p. 61 11. Chapter 8: Collapsing Glomerulopathy - p. 69 12. Chapter 9: Focal Segmental Glomerulosclerosis, Adaptive (Secondary) - p. 79 13. Chapter 10: Metabolic Syndrome/Obesity-Related Glomerular Disease - p. 85 14. MEMBRANOUS GLOMERULONEPHRITIS - p. 89 15. Chapter 11: Etiologies of Membranous Glomerulonephritis - p. 89 16. Chapter 12: Membranous Glomerulonephritis, Primary - p. 91 17. Chapter 13: Membranous Glomerulonephritis, Secondary - p. 97 18. Chapter 14: Membranous Glomerulonephritis With Anti-TBM Antibodies - p. 101 19. C3-RELATED GLOMERULONEPHRITIS AND MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS - p. 103 20. Chapter 15: Classification of MPGN and Complement-Related Diseases - p. 103 21. Chapter 16: Dense Deposit Disease - p. 107 22. Chapter 17: C3 Glomerulonephritis - p. 113 23. Chapter 18: Membranoproliferative Glomerulonephritis With Immune Complexes - p. 119 24. IMMUNOGLOBULIN A-RELATED GLOMERULONEPHRITIS - p. 127 25. Chapter 19: Overview of IgA-Related Glomerular Diseases - p. 127 26. Chapter 20: IgA Nephropathy - p. 131 27. Chapter 21: IgA Vasculitis (Henoch-Schönlein Purpura) - p. 145 28. Chapter 22: IgA Acute Glomerulonephritis Associated With *Staphylococcus aureus* - p. 151 29. Chapter 23: Hepatic Disease With IgA Deposition - p. 155 30. SLE AND RELATED AUTOANTIBODYMEDIATED DISEASES - p. 157 31. Chapter 24: Systemic Lupus Erythematosus - p. 157 32. Chapter 25: Mixed Connective Tissue Disease - p. 175 33. Chapter 26: Rheumatoid Arthritis - p. 177 34. Chapter 27: Mixed Cryoglobulinemic Glomerulonephritis - p. 183 35. Chapter 28: Idiopathic Nonlupus Full-House Nephropathy - p. 189 36. ANTI-GBM DISEASES - p. 191 37. Chapter 29: Anti-GBM Glomerulonephritis - p. 191 38. Chapter 30: Atypical Anti-GBM Disease - p. 199 39. MONOCLONAL IMMUNOGLOBULIN DISEASES OF GLOMERULI - p. 203 40. Chapter 31: Introduction to Diseases With Monoclonal Immunoglobulin Deposits - p. 203 41. Chapter 32: Monoclonal Immunoglobulin Deposition Disease - p. 207 42. Chapter 33: Proliferative Glomerulonephritis With Monoclonal IgG Deposits - p. 215 43. Chapter 34: Membranous Glomerulonephritis With Masked IgG κ Deposits - p. 219 44. Chapter 35: Type I Cryoglobulinemic Glomerulonephritis - p. 223 45. Chapter 36: Waldenström Macroglobulinemia - p. 227 46. AMYLOIDOSIS - p. 229 47. Chapter 37: Amyloidosis Classification - p. 229 48. Chapter 38: AL/AH Amyloidosis - p. 235 49. Chapter 39: AA Amyloidosis - p. 241 50. Chapter 40: AFib Amyloidosis - p. 245 51. Chapter 41: AGel Amyloidosis - p. 247 52. Chapter 42: ALECT2 Amyloidosis - p. 249 53. Chapter 43: AApoAI Amyloidosis - p. 251 54. Chapter 44: AApoAII Amyloidosis - p. 252 55. Chapter 45: AApoAIV Amyloidosis - p. 253 56. Chapter 46: AApoCII Amyloidosis - p. 254 57. Chapter 47: ATTR Amyloidosis - p. 255 58. IDIOPATHIC FIBRILLARY GLOMERULOPATHIES - p. 257 59. Chapter 48: Diseases With Organized Deposits - p. 257 60. Chapter 49: Fibrillary Glomerulopathy - p. 261 61. Chapter 50: Immunotactoid Glomerulopathy - p. 265 62. Chapter 51: Fibronectin Glomerulopathy - p. 269 63. DIABETIC RENAL DISEASE - p. 273 64. Chapter 52: Diabetic Nephropathy - p. 273 65. Chapter 53: Idiopathic Nodular Glomerulopathy - p. 283 66. INFECTION-RELATED GLOMERULAR DISEASE - p. 287 67. Chapter 54: Overview of Infection-Related Glomerular Disease - p. 287 68. Chapter 55: Poststreptococcal Acute Glomerulonephritis - p. 291 69. Chapter 56: Postinfectious Acute Glomerulonephritis, Nonstreptococcal - p. 299 70. Chapter 57: Glomerulonephritis of Chronic Infection, Including Shunt Nephritis - p. 305 71. Chapter 58: Endocarditis - p. 307 72. Chapter 59: Syphilis - p. 311 73. Chapter 60: Lyme Disease - p. 313 74. Chapter 61: Hepatitis B Virus - p. 315 75. Chapter 62: Hepatitis C Virus - p. 319 76. Chapter 63: HIV-Associated Nephropathy - p. 323 77. Chapter 64: Miscellaneous HIV-Associated Renal Diseases - p. 329 78. Chapter 65: Schistosomiasis - p. 335 79. Chapter 66: Filariasis - p. 337 80. Chapter 67: Leishmaniasis - p. 338 81. DRUG-INDUCED GLOMERULAR DISEASES - p. 339 82. Chapter 68: Drug-Induced Minimal Change Disease - p. 339 83. Chapter 69: Bisphosphonate-Induced Collapsing Glomerulopathy - p. 341 84. Chapter 70: Chloroquine Toxicity - p. 342 85. Chapter 71: Antihepatitis C Virus Drugs - p. 343 86. Chapter 72: Anti-EGFR Drugs - p. 347 87. GENETIC DISEASES OF GLOMERULUS - p. 349 88. Chapter 73: Overview and Classification of Genetic Diseases of Glomerulus - p. 349 89. GENETIC DISEASES OF GBM COLLAGEN - p. 351 90. Chapter 74: Alport Syndrome - p. 351 91. Chapter 75: Thin Basement Membrane Disease - p. 363 92. GENETIC DISEASES OF PODOCYTE - p. 365 93. Chapter 76: *APOL1*-Related Glomerular Disease - p. 365 94. Chapter 77: Diffuse Mesangial Sclerosis - p. 369 95. Chapter 78: Congenital Nephrotic Syndrome of Finnish Type - p. 373 96. Chapter 79: Pierson Syndrome - p. 377 97. Chapter 80: Galloway-Mowat Syndrome - p. 379 98. Chapter 81: Denys-Drash Syndrome - p. 381 99. Chapter 82: Frasier Syndrome - p. 385 100. Chapter 83: Podocin Deficiency - p. 389 101. Chapter 84: α-Actinin-4 Deficiency - p. 391 102. Chapter 85: Autosomal Dominant FSGS Due To *INF2* Mutations - p. 393 103. Chapter 86: Schimke Immunoosseous Dysplasia - p. 395 104. GENETIC STORAGE AND LIPID DISEASES - p. 397 105. Chapter 87: Fabry Disease - p. 397 106. Chapter 88: Lecithin-Cholesterol Acyltransferase Deficiency - p. 405 107. Chapter 89: APOE Lipoprotein Glomerulopathy - p. 409 108. Chapter 90: Type III Hyperlipoproteinemia - p. 411 109. Chapter 91: Gaucher Glomerulopathy - p. 413 110. Chapter 92: I-Cell Disease (Mucolipidosis II) - p. 415 111. Chapter 93: Alagille Syndrome - p. 417 112. OTHER GENETIC DISEASES AFFECTING GLOMERULUS - p. 419 113. Chapter 94: Nail-Patella Syndrome - p. 419 114. Chapter 95: Type III Collagen Glomerulopathy - p. 421 115. Chapter 96: Glomerulopathy of Hereditary Multiple Exostoses - p. 425 116. MISCELLANEOUS GLOMERULAR DISEASES - p. 427 117. Chapter 97: C1q Nephropathy - p. 427 118. Chapter 98: IgM Nephropathy - p. 433 119. Chapter 99: Cryofibrinogenic Glomerulopathy - p. 435 120. Chapter 100: Hemophagocytic Glomerulopathy - p. 439 121. Chapter 101: Podocyte Infolding Glomerulopathy - p. 443 122. Chapter 102: Intravascular Large B-Cell Lymphoma - p. 445 123. SECTION 3: VASCULAR DISEASES - p. 447 124. Chapter 103: Overview and Classification of Systemic Vasculitides - p. 447 125. ANCA DISEASES - p. 459 126. Chapter 104: ANCA-Related Glomerulonephritis - p. 459 127. Chapter 105: Microscopic Polyangiitis - p. 465 128. Chapter 106: Granulomatosis With Polyangiitis - p. 472 129. Chapter 107: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) - p. 483 130. Chapter 108: Drug-Induced ANCA Vasculitis - p. 489 131. NON-ANCA VASCULITIDES - p. 493 132. Chapter 109: Polyarteritis Nodosa - p. 493 133. Chapter 110: Kawasaki Disease - p. 499 134. Chapter 111: Giant Cell Arteritis - p. 501 135. Chapter 112: Takayasu Arteritis - p. 505 136. Chapter 113: Hypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis) - p. 509 137. THROMBOTIC MICROANGIOPATHIES - p. 511 138. Chapter 114: Introduction to Thrombotic Microangiopathies - p. 511 139. Chapter 115: Hemolytic Uremic Syndrome, Infection Related - p. 517 140. Chapter 116: Thrombotic Microangiopathy, Genetic - p. 523 141. Chapter 117: Thrombotic Microangiopathy, Autoimmune - p. 527 142. Chapter 118: Thrombotic Microangiopathy, Drug Induced - p. 531 143. Chapter 119: Postpartum Hemolytic Uremic Syndrome - p. 535 144. Chapter 120: Scleroderma Renal Disease - p. 539 145. Chapter 121: Multicentric Castleman Disease - p. 545 146. OTHER DISEASES AFFECTING ENDOTHELIUM - p. 547 147. Chapter 122: Preeclampsia, Eclampsia, HELLP Syndrome - p. 547 148. Chapter 123: Radiation Nephropathy - p. 549 149. Chapter 124: Retinal Vasculopathy and Cerebral Leukodystrophy - p. 551 150. Chapter 125: Sickle Cell Nephropathy - p. 553 151. HYPERTENSIVE RENAL DISEASE - p. 557 152. Chapter 126: Hypertensive Renovascular Disease - p. 557 153. Chapter 127: Renal Artery Stenosis - p. 565 154. Chapter 128: Fibromuscular Dysplasia - p. 569 155. Chapter 129: Neurofibromatosis - p. 575 156. THROMBOTIC AND EMBOLIC DISEASE - p. 579 157. Chapter 130: Renal Vein Thrombosis - p. 579 158. Chapter 131: Renal Artery Thrombosis - p. 581 159. Chapter 132: Atheromatous Emboli - p. 583 160. Chapter 133: Hydrophilic Polymer Emboli - p. 585 161. SECTION 4: TUBULOINTERSTITIAL DISEASES - p. 587 162. Chapter 134: Overview and Classification of Tubulointerstitial Diseases - p. 587 163. Chapter 135: Differential Diagnosis of Acute Interstitial Nephritis - p. 591 164. ISCHEMIC INJURY - p. 597 165. Chapter 136: Acute Tubular Injury - p. 597 166. Chapter 137: Renal Cortical Necrosis - p. 603 167. Chapter 138: Septicemia/Shock - p. 605 168. IMMUNOLOGIC TUBULOINTERSTITIAL DISEASE - p. 607 169. Chapter 139: Tubulointerstitial Nephritis With Uveitis - p. 607 170. Chapter 140: Sjögren Syndrome - p. 611 171. Chapter 141: IgG4-Related Kidney Disease - p. 615 172. Chapter 142: Idiopathic Hypocomplementemic Tubulointerstitial Nephritis - p. 625 173. Chapter 143: Anti-TBM Disease - p. 627 174. Chapter 144: Antibrush Border Autoantibody Tubulointerstitial Nephritis - p. 629 175. Chapter 145: Sarcoidosis - p. 631 176. Chapter 146: Tubulointerstitial Nephritis With IgM(+) Plasma Cells - p. 635 177. MONOCLONAL IMMUNOGLOBULIN DISEASES OF TUBULES - p. 637 178. Chapter 147: Light Chain Cast Nephropathy - p. 637 179. Chapter 148: Light Chain Proximal Tubulopathy With Crystals - p. 643 180. Chapter 149: Light Chain Proximal Tubulopathy Without Crystals - p. 647 181. DRUG-INDUCED TUBULOINTERSTITIAL DISEASES - p. 651 182. Chapter 150: Drug-Induced Acute Interstitial Nephritis - p. 651 183. Chapter 151: Drugs That Cause Tubulointerstitial Nephritis - p. 657 184. Chapter 152: Checkpoint Inhibitor-Induced Kidney Diseases - p. 659 185. Chapter 153: Papillary Necrosis - p. 663 186. Chapter 154: Cisplatin Nephrotoxicity - p. 667 187. Chapter 155: Osmotic Tubulopathy - p. 669 188. Chapter 156: Antiviral Drug Nephrotoxicity - p. 673 189. Chapter 157: Acute Phosphate Nephropathy - p. 679 190. Chapter 158: Lithium-Induced Renal Disease - p. 681 191. Chapter 159: Calcineurin Inhibitor Toxicity - p. 683 192. Chapter 160: mTOR Inhibitor Toxicity - p. 689 193. Chapter 161: Vancomycin-Induced Cast Nephropathy - p. 691 194. Chapter 162: Anticoagulant-Related Nephropathy - p. 693 195. Chapter 163: Giant Cell Tubulitis With TBM Deposits - p. 695 196. Chapter 164: Illicit Drugs and Opioids - p. 697 197. TOXIC INJURY - p. 699 198. Chapter 165: Myoglobinuria/Rhabdomyolysis/Hemoglobinuria - p. 699 199. Chapter 166: Bile Cast Nephropathy - p. 701 200. Chapter 167: Lead and Other Heavy Metal Toxins - p. 703 201. Chapter 168: Aristolochic Acid Nephropathy - p. 707 202. Chapter 169: Balkan Endemic Nephropathy - p. 709 203. Chapter 170: Ethylene Glycol Toxicity - p. 711 204. Chapter 171: Argyria - p. 713 205. AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE - p. 715 206. Chapter 172: *MUC1*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 715 207. Chapter 173: *UMOD*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 717 208. Chapter 174: *REN*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 719 209. Chapter 175: *HNF1B*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 721 210. GENETIC CRYSTAL DEPOSITION DISEASES - p. 723 211. Chapter 176: Primary Hyperoxaluria - p. 723 212. Chapter 177: 2,8-Dihydroxyadeninuria - p. 725 213. Chapter 178: Cystinosis - p. 727 214. Chapter 179: Uric Acid Nephropathy/Gout - p. 729 215. GENETIC TRANSPORT DISEASES - p. 733 216. Chapter 180: Bartter Syndrome - p. 733 217. Chapter 181: Dent Disease - p. 735 218. Chapter 182: Oculocerebrorenal Syndrome of Lowe - p. 737 219. OTHER GENETIC DISEASES AFFECTING TUBULES - p. 739 220. Chapter 183: Methylmalonic Acidemia - p. 739 221. Chapter 184: Systemic Karyomegaly - p. 743 222. Chapter 185: Mitochondriopathies - p. 745 223. MISCELLANEOUS TUBULOINTERSTITIAL DISEASES - p. 749 224. Chapter 186: Nephrocalcinosis - p. 749 225. Chapter 187: Secondary Oxalosis - p. 751 226. Chapter 188: Mesoamerican Nephropathy - p. 753 227. Chapter 189: Extramedullary Hematopoiesis - p. 755 228. SECTION 5: INFECTIONS OF KIDNEY - p. 759 229. BACTERIAL INFECTIONS OF KIDNEY - p. 759 230. Chapter 190: Acute Pyelonephritis - p. 759 231. Chapter 191: Chronic Pyelonephritis - p. 769 232. Chapter 192: Xanthogranulomatous Pyelonephritis - p. 773 233. Chapter 193: Malakoplakia - p. 777 234. Chapter 194: Tuberculosis - p. 781 235. Chapter 195: BCG Granulomatous Interstitial Nephritis - p. 783 236. Chapter 196: Leprosy - p. 785 237. Chapter 197: Megalocytic Interstitial Nephritis - p. 786 238. Chapter 198: Nocardiosis - p. 787 239. Chapter 199: Leptospirosis - p. 789 240. Chapter 200: Whipple Disease - p. 791 241. FUNGAL, RICKETTSIAL, AND PARASITIC INFECTIONS OF KIDNEY - p. 793 242. Chapter 201: Mucormycosis - p. 793 243. Chapter 202: Candidiasis - p. 795 244. Chapter 203: Histoplasmosis - p. 796 245. Chapter 204: Coccidioidomycosis - p. 797 246. Chapter 205: Blastomycosis - p. 798 247. Chapter 206: Paracoccidioidomycosis - p. 799 248. Chapter 207: Aspergillosis - p. 800 249. Chapter 208: Cryptococcosis - p. 801 250. Chapter 209: Microsporidiosis - p. 802 251. Chapter 210: Rickettsial Infections - p. 803 252. Chapter 211: Toxoplasmosis - p. 805 253. Chapter 212: Hydatidosis - p. 807 254. VIRAL INFECTIONS OF KIDNEY - p. 809 255. Chapter 213: Polyomavirus Nephritis - p. 809 256. Chapter 214: Cytomegalovirus Infection - p. 817 257. Chapter 215: Adenovirus Infection - p. 819 258. Chapter 216: Epstein-Barr Virus Nephritis - p. 821 259. Chapter 217: Herpes Simplex Acute Nephritis - p. 823 260. Chapter 218: Hantavirus Nephropathy - p. 824 261. SECTION 6: DEVELOPMENTAL DISEASES - p. 825 262. Chapter 219: Overview of Congenital Anomalies of Kidney and Urinary Tract - p. 825 263. Chapter 220: Dysplasia/Hypoplasia/Agenesis - p. 831 264. Chapter 221: Oligomeganephronia - p. 837 265. Chapter 222: Ectopia, Malrotation, Duplication, Fusion, Supernumerary Kidney - p. 839 266. Chapter 223: Ask-Upmark Kidney - p. 843 267. Chapter 224: Renal Tubular Dysgenesis - p. 845 268. SECTION 7: CYSTIC DISEASES - p. 849 269. Chapter 225: Overview of Cystic Diseases - p. 849 270. CILIOPATHIES - p. 857 271. Chapter 226: Autosomal Dominant Polycystic Kidney Disease - p. 857 272. Chapter 227: Autosomal Recessive Polycystic Kidney Disease - p. 863 273. Chapter 228: Nephronophthisis and Related Ciliopathies - p. 869 274. OTHER GENETIC CYSTIC DISEASES - p. 875 275. Chapter 229: von Hippel-Lindau Disease - p. 875 276. Chapter 230: Tuberous Sclerosis Complex - p. 881 277. Chapter 231: Zellweger Syndrome - p. 887 278. MISCELLANEOUS CYSTIC DISEASES - p. 889 279. Chapter 232: Medullary Sponge Kidney - p. 889 280. Chapter 233: Simple and Miscellaneous Cysts - p. 891 281. Chapter 234: Acquired Cystic Disease - p. 893 282. Chapter 235: Mixed Epithelial and Stromal Tumor Family - p. 897 283. Chapter 236: Pediatric Cystic Nephroma - p. 903 284. Chapter 237: Renal Lymphangioma/Lymphangiectasia - p. 907 285. SECTION 8: DISEASES OF COLLECTING SYSTEM - p. 911 286. Chapter 238: Introduction to Impediments to Urine Flow - p. 911 287. Chapter 239: Reflux Nephropathy - p. 917 288. Chapter 240: Obstructive Uropathy - p. 921 289. Chapter 241: Nephrolithiasis - p. 925 290. Chapter 242: Loin Pain Hematuria Syndrome - p. 931 291. SECTION 9: DISEASES OF RENAL ALLOGRAFT - p. 933 292. INTRODUCTION - p. 933 293. Chapter 243: Pathologic Classification of Renal Allograft Diseases - p. 933 294. Chapter 244: Evaluation of Allograft Kidney - p. 937 295. Chapter 245: Evaluation of Donor Kidney - p. 943 296. IMMUNOLOGIC REJECTION - p. 949 297. Chapter 246: Acute T-Cell-Mediated Rejection - p. 949 298. Chapter 247: Chronic T-Cell-Mediated Rejection - p. 961 299. Chapter 248: Hyperacute Rejection - p. 965 300. Chapter 249: Acute Antibody-Mediated Rejection - p. 969 301. Chapter 250: Chronic Antibody-Mediated Rejection - p. 977 302. Chapter 251: Transcript Analysis of Renal Transplant Biopsies - p. 989 303. RECURRENT AND DE NOVO DISEASES - p. 993 304. Chapter 252: Diseases That Recur in Allografts - p. 993 305. Chapter 253: De Novo Focal Segmental Glomerulosclerosis - p. 999 306. Chapter 254: De Novo Membranous Glomerulonephritis - p. 1001 307. Chapter 255: Anti-GBM Disease in Alport Syndrome - p. 1005 308. Chapter 256: Engraftment Syndrome - p. 1007 309. NONIMMUNOLOGIC INJURY - p. 1009 310. Chapter 257: Acute Allograft Ischemia - p. 1009 311. Chapter 258: Hyperperfusion Injury - p. 1013 312. Chapter 259: Urine Leak - p. 1014 313. Chapter 260: Lymphocele - p. 1015 314. Chapter 261: Transplant Renal Artery Stenosis - p. 1016 315. Chapter 262: Renal Artery or Vein Thrombosis - p. 1017 316. Chapter 263: Posttransplant Lymphoproliferative Disease - p. 1019 317. Chapter 264: BK Polyomavirus Neoplasia - p. 1029 318. STABLE AND ACCEPTED GRAFTS - p. 1031 319. Chapter 265: Protocol Biopsies - p. 1031 320. Chapter 266: Accommodation - p. 1035 321. Chapter 267: Tolerance - p. 1037 322. NATIVE KIDNEY PATHOLOGY IN RECIPIENTS OF OTHER TRANSPLANTS - p. 1041 323. Chapter 268: Kidney Diseases in Nonrenal Transplant Recipients - p. 1041 324. Chapter 269: Graft-vs.-Host Glomerulopathies - p. 1045 325. SECTION 10: PROTOCOLS - p. 1047 326. Chapter 270: Kidney Biopsy Reports - p. 1047 327. Chapter 271: Kidney Needle Biopsy - p. 1051 328. Chapter 272: Examination of End-Stage Kidney - p. 1055 329. Chapter 273: Examination of Tumor Nephrectomy Specimens for Nonneoplastic Diseases - p. 1061 330. Chapter 274: Evaluation of Transplant Nephrectomy - p. 1065 331. Chapter 275: Evaluation of Autopsy Kidneys - p. 1069 332. SECTION 11: SPECIALIZED TECHNIQUES - p. 1073 333. Chapter 276: Evaluation of Fibrosis - p. 1073 334. Chapter 277: Immunofluorescence on Paraffin Tissue Sections - p. 1079 335. Chapter 278: Electron Microscopy Processing From Paraffin Tissue - p. 1083 336. Chapter 279: Detection of PLA2R1 Deposits and Autoantibodies - p. 1085 337. Chapter 280: Alport Collagen IV Immunofluorescence - p. 1087 338. Chapter 281: C4d Immunohistochemistry/Immunofluorescence - p. 1089 339. Chapter 282: Polyomavirus Detection in Tissue - p. 1093 340. Chapter 283: Mass Spectrometry - p. 1095 341. Chapter 284: Diagnostic Genetics of Kidney Diseases - p. 1097 342. INDEX - p. 1101
No hay muestra disponible
No hay ficha técnica disponible
Comprehensive and up to date, the third edition of Diagnostic Pathology: Kidney Diseases, written by Robert B. Colvin, MD and Anthony Chang, MD, expertly covers all aspects of common and rare renal diseases and their variants. This easy-to-use, point-of-care reference offers a state-of-the-art, concise presentation of major pathological, clinical, pathophysiological, and genetic information for more than 240 diagnoses, making it an ideal resource for pathologists and nephrologists to improve knowledge and skills. Significantly revised information throughout ensures that you remain current with everything new regarding the pathology and pathogenesis of nonneoplastic kidney diseases.
1. SECTION 1: INTRODUCTION AND OVERVIEW - p. xxiv 2. Chapter 1: Introduction to Renal Pathology - p. xxiv 3. Chapter 2: Normal Kidney Structure - p. 23 4. Chapter 3: Normal Kidney Development - p. 35 5. SECTION 2: GLOMERULAR DISEASES - p. 45 6. PODOCYTOPATHIES - p. 45 7. Chapter 4: Minimal Change Disease - p. 45 8. Chapter 5: Classification of Focal Segmental Glomerulosclerosis - p. 55 9. Chapter 6: Etiologies of Focal Segmental Glomerulosclerosis - p. 59 10. Chapter 7: Focal Segmental Glomerulosclerosis, Primary - p. 61 11. Chapter 8: Collapsing Glomerulopathy - p. 69 12. Chapter 9: Focal Segmental Glomerulosclerosis, Adaptive (Secondary) - p. 79 13. Chapter 10: Metabolic Syndrome/Obesity-Related Glomerular Disease - p. 85 14. MEMBRANOUS GLOMERULONEPHRITIS - p. 89 15. Chapter 11: Etiologies of Membranous Glomerulonephritis - p. 89 16. Chapter 12: Membranous Glomerulonephritis, Primary - p. 91 17. Chapter 13: Membranous Glomerulonephritis, Secondary - p. 97 18. Chapter 14: Membranous Glomerulonephritis With Anti-TBM Antibodies - p. 101 19. C3-RELATED GLOMERULONEPHRITIS AND MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS - p. 103 20. Chapter 15: Classification of MPGN and Complement-Related Diseases - p. 103 21. Chapter 16: Dense Deposit Disease - p. 107 22. Chapter 17: C3 Glomerulonephritis - p. 113 23. Chapter 18: Membranoproliferative Glomerulonephritis With Immune Complexes - p. 119 24. IMMUNOGLOBULIN A-RELATED GLOMERULONEPHRITIS - p. 127 25. Chapter 19: Overview of IgA-Related Glomerular Diseases - p. 127 26. Chapter 20: IgA Nephropathy - p. 131 27. Chapter 21: IgA Vasculitis (Henoch-Schönlein Purpura) - p. 145 28. Chapter 22: IgA Acute Glomerulonephritis Associated With *Staphylococcus aureus* - p. 151 29. Chapter 23: Hepatic Disease With IgA Deposition - p. 155 30. SLE AND RELATED AUTOANTIBODYMEDIATED DISEASES - p. 157 31. Chapter 24: Systemic Lupus Erythematosus - p. 157 32. Chapter 25: Mixed Connective Tissue Disease - p. 175 33. Chapter 26: Rheumatoid Arthritis - p. 177 34. Chapter 27: Mixed Cryoglobulinemic Glomerulonephritis - p. 183 35. Chapter 28: Idiopathic Nonlupus Full-House Nephropathy - p. 189 36. ANTI-GBM DISEASES - p. 191 37. Chapter 29: Anti-GBM Glomerulonephritis - p. 191 38. Chapter 30: Atypical Anti-GBM Disease - p. 199 39. MONOCLONAL IMMUNOGLOBULIN DISEASES OF GLOMERULI - p. 203 40. Chapter 31: Introduction to Diseases With Monoclonal Immunoglobulin Deposits - p. 203 41. Chapter 32: Monoclonal Immunoglobulin Deposition Disease - p. 207 42. Chapter 33: Proliferative Glomerulonephritis With Monoclonal IgG Deposits - p. 215 43. Chapter 34: Membranous Glomerulonephritis With Masked IgG κ Deposits - p. 219 44. Chapter 35: Type I Cryoglobulinemic Glomerulonephritis - p. 223 45. Chapter 36: Waldenström Macroglobulinemia - p. 227 46. AMYLOIDOSIS - p. 229 47. Chapter 37: Amyloidosis Classification - p. 229 48. Chapter 38: AL/AH Amyloidosis - p. 235 49. Chapter 39: AA Amyloidosis - p. 241 50. Chapter 40: AFib Amyloidosis - p. 245 51. Chapter 41: AGel Amyloidosis - p. 247 52. Chapter 42: ALECT2 Amyloidosis - p. 249 53. Chapter 43: AApoAI Amyloidosis - p. 251 54. Chapter 44: AApoAII Amyloidosis - p. 252 55. Chapter 45: AApoAIV Amyloidosis - p. 253 56. Chapter 46: AApoCII Amyloidosis - p. 254 57. Chapter 47: ATTR Amyloidosis - p. 255 58. IDIOPATHIC FIBRILLARY GLOMERULOPATHIES - p. 257 59. Chapter 48: Diseases With Organized Deposits - p. 257 60. Chapter 49: Fibrillary Glomerulopathy - p. 261 61. Chapter 50: Immunotactoid Glomerulopathy - p. 265 62. Chapter 51: Fibronectin Glomerulopathy - p. 269 63. DIABETIC RENAL DISEASE - p. 273 64. Chapter 52: Diabetic Nephropathy - p. 273 65. Chapter 53: Idiopathic Nodular Glomerulopathy - p. 283 66. INFECTION-RELATED GLOMERULAR DISEASE - p. 287 67. Chapter 54: Overview of Infection-Related Glomerular Disease - p. 287 68. Chapter 55: Poststreptococcal Acute Glomerulonephritis - p. 291 69. Chapter 56: Postinfectious Acute Glomerulonephritis, Nonstreptococcal - p. 299 70. Chapter 57: Glomerulonephritis of Chronic Infection, Including Shunt Nephritis - p. 305 71. Chapter 58: Endocarditis - p. 307 72. Chapter 59: Syphilis - p. 311 73. Chapter 60: Lyme Disease - p. 313 74. Chapter 61: Hepatitis B Virus - p. 315 75. Chapter 62: Hepatitis C Virus - p. 319 76. Chapter 63: HIV-Associated Nephropathy - p. 323 77. Chapter 64: Miscellaneous HIV-Associated Renal Diseases - p. 329 78. Chapter 65: Schistosomiasis - p. 335 79. Chapter 66: Filariasis - p. 337 80. Chapter 67: Leishmaniasis - p. 338 81. DRUG-INDUCED GLOMERULAR DISEASES - p. 339 82. Chapter 68: Drug-Induced Minimal Change Disease - p. 339 83. Chapter 69: Bisphosphonate-Induced Collapsing Glomerulopathy - p. 341 84. Chapter 70: Chloroquine Toxicity - p. 342 85. Chapter 71: Antihepatitis C Virus Drugs - p. 343 86. Chapter 72: Anti-EGFR Drugs - p. 347 87. GENETIC DISEASES OF GLOMERULUS - p. 349 88. Chapter 73: Overview and Classification of Genetic Diseases of Glomerulus - p. 349 89. GENETIC DISEASES OF GBM COLLAGEN - p. 351 90. Chapter 74: Alport Syndrome - p. 351 91. Chapter 75: Thin Basement Membrane Disease - p. 363 92. GENETIC DISEASES OF PODOCYTE - p. 365 93. Chapter 76: *APOL1*-Related Glomerular Disease - p. 365 94. Chapter 77: Diffuse Mesangial Sclerosis - p. 369 95. Chapter 78: Congenital Nephrotic Syndrome of Finnish Type - p. 373 96. Chapter 79: Pierson Syndrome - p. 377 97. Chapter 80: Galloway-Mowat Syndrome - p. 379 98. Chapter 81: Denys-Drash Syndrome - p. 381 99. Chapter 82: Frasier Syndrome - p. 385 100. Chapter 83: Podocin Deficiency - p. 389 101. Chapter 84: α-Actinin-4 Deficiency - p. 391 102. Chapter 85: Autosomal Dominant FSGS Due To *INF2* Mutations - p. 393 103. Chapter 86: Schimke Immunoosseous Dysplasia - p. 395 104. GENETIC STORAGE AND LIPID DISEASES - p. 397 105. Chapter 87: Fabry Disease - p. 397 106. Chapter 88: Lecithin-Cholesterol Acyltransferase Deficiency - p. 405 107. Chapter 89: APOE Lipoprotein Glomerulopathy - p. 409 108. Chapter 90: Type III Hyperlipoproteinemia - p. 411 109. Chapter 91: Gaucher Glomerulopathy - p. 413 110. Chapter 92: I-Cell Disease (Mucolipidosis II) - p. 415 111. Chapter 93: Alagille Syndrome - p. 417 112. OTHER GENETIC DISEASES AFFECTING GLOMERULUS - p. 419 113. Chapter 94: Nail-Patella Syndrome - p. 419 114. Chapter 95: Type III Collagen Glomerulopathy - p. 421 115. Chapter 96: Glomerulopathy of Hereditary Multiple Exostoses - p. 425 116. MISCELLANEOUS GLOMERULAR DISEASES - p. 427 117. Chapter 97: C1q Nephropathy - p. 427 118. Chapter 98: IgM Nephropathy - p. 433 119. Chapter 99: Cryofibrinogenic Glomerulopathy - p. 435 120. Chapter 100: Hemophagocytic Glomerulopathy - p. 439 121. Chapter 101: Podocyte Infolding Glomerulopathy - p. 443 122. Chapter 102: Intravascular Large B-Cell Lymphoma - p. 445 123. SECTION 3: VASCULAR DISEASES - p. 447 124. Chapter 103: Overview and Classification of Systemic Vasculitides - p. 447 125. ANCA DISEASES - p. 459 126. Chapter 104: ANCA-Related Glomerulonephritis - p. 459 127. Chapter 105: Microscopic Polyangiitis - p. 465 128. Chapter 106: Granulomatosis With Polyangiitis - p. 472 129. Chapter 107: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) - p. 483 130. Chapter 108: Drug-Induced ANCA Vasculitis - p. 489 131. NON-ANCA VASCULITIDES - p. 493 132. Chapter 109: Polyarteritis Nodosa - p. 493 133. Chapter 110: Kawasaki Disease - p. 499 134. Chapter 111: Giant Cell Arteritis - p. 501 135. Chapter 112: Takayasu Arteritis - p. 505 136. Chapter 113: Hypocomplementemic Urticarial Vasculitis (Anti-C1q Vasculitis) - p. 509 137. THROMBOTIC MICROANGIOPATHIES - p. 511 138. Chapter 114: Introduction to Thrombotic Microangiopathies - p. 511 139. Chapter 115: Hemolytic Uremic Syndrome, Infection Related - p. 517 140. Chapter 116: Thrombotic Microangiopathy, Genetic - p. 523 141. Chapter 117: Thrombotic Microangiopathy, Autoimmune - p. 527 142. Chapter 118: Thrombotic Microangiopathy, Drug Induced - p. 531 143. Chapter 119: Postpartum Hemolytic Uremic Syndrome - p. 535 144. Chapter 120: Scleroderma Renal Disease - p. 539 145. Chapter 121: Multicentric Castleman Disease - p. 545 146. OTHER DISEASES AFFECTING ENDOTHELIUM - p. 547 147. Chapter 122: Preeclampsia, Eclampsia, HELLP Syndrome - p. 547 148. Chapter 123: Radiation Nephropathy - p. 549 149. Chapter 124: Retinal Vasculopathy and Cerebral Leukodystrophy - p. 551 150. Chapter 125: Sickle Cell Nephropathy - p. 553 151. HYPERTENSIVE RENAL DISEASE - p. 557 152. Chapter 126: Hypertensive Renovascular Disease - p. 557 153. Chapter 127: Renal Artery Stenosis - p. 565 154. Chapter 128: Fibromuscular Dysplasia - p. 569 155. Chapter 129: Neurofibromatosis - p. 575 156. THROMBOTIC AND EMBOLIC DISEASE - p. 579 157. Chapter 130: Renal Vein Thrombosis - p. 579 158. Chapter 131: Renal Artery Thrombosis - p. 581 159. Chapter 132: Atheromatous Emboli - p. 583 160. Chapter 133: Hydrophilic Polymer Emboli - p. 585 161. SECTION 4: TUBULOINTERSTITIAL DISEASES - p. 587 162. Chapter 134: Overview and Classification of Tubulointerstitial Diseases - p. 587 163. Chapter 135: Differential Diagnosis of Acute Interstitial Nephritis - p. 591 164. ISCHEMIC INJURY - p. 597 165. Chapter 136: Acute Tubular Injury - p. 597 166. Chapter 137: Renal Cortical Necrosis - p. 603 167. Chapter 138: Septicemia/Shock - p. 605 168. IMMUNOLOGIC TUBULOINTERSTITIAL DISEASE - p. 607 169. Chapter 139: Tubulointerstitial Nephritis With Uveitis - p. 607 170. Chapter 140: Sjögren Syndrome - p. 611 171. Chapter 141: IgG4-Related Kidney Disease - p. 615 172. Chapter 142: Idiopathic Hypocomplementemic Tubulointerstitial Nephritis - p. 625 173. Chapter 143: Anti-TBM Disease - p. 627 174. Chapter 144: Antibrush Border Autoantibody Tubulointerstitial Nephritis - p. 629 175. Chapter 145: Sarcoidosis - p. 631 176. Chapter 146: Tubulointerstitial Nephritis With IgM(+) Plasma Cells - p. 635 177. MONOCLONAL IMMUNOGLOBULIN DISEASES OF TUBULES - p. 637 178. Chapter 147: Light Chain Cast Nephropathy - p. 637 179. Chapter 148: Light Chain Proximal Tubulopathy With Crystals - p. 643 180. Chapter 149: Light Chain Proximal Tubulopathy Without Crystals - p. 647 181. DRUG-INDUCED TUBULOINTERSTITIAL DISEASES - p. 651 182. Chapter 150: Drug-Induced Acute Interstitial Nephritis - p. 651 183. Chapter 151: Drugs That Cause Tubulointerstitial Nephritis - p. 657 184. Chapter 152: Checkpoint Inhibitor-Induced Kidney Diseases - p. 659 185. Chapter 153: Papillary Necrosis - p. 663 186. Chapter 154: Cisplatin Nephrotoxicity - p. 667 187. Chapter 155: Osmotic Tubulopathy - p. 669 188. Chapter 156: Antiviral Drug Nephrotoxicity - p. 673 189. Chapter 157: Acute Phosphate Nephropathy - p. 679 190. Chapter 158: Lithium-Induced Renal Disease - p. 681 191. Chapter 159: Calcineurin Inhibitor Toxicity - p. 683 192. Chapter 160: mTOR Inhibitor Toxicity - p. 689 193. Chapter 161: Vancomycin-Induced Cast Nephropathy - p. 691 194. Chapter 162: Anticoagulant-Related Nephropathy - p. 693 195. Chapter 163: Giant Cell Tubulitis With TBM Deposits - p. 695 196. Chapter 164: Illicit Drugs and Opioids - p. 697 197. TOXIC INJURY - p. 699 198. Chapter 165: Myoglobinuria/Rhabdomyolysis/Hemoglobinuria - p. 699 199. Chapter 166: Bile Cast Nephropathy - p. 701 200. Chapter 167: Lead and Other Heavy Metal Toxins - p. 703 201. Chapter 168: Aristolochic Acid Nephropathy - p. 707 202. Chapter 169: Balkan Endemic Nephropathy - p. 709 203. Chapter 170: Ethylene Glycol Toxicity - p. 711 204. Chapter 171: Argyria - p. 713 205. AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE - p. 715 206. Chapter 172: *MUC1*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 715 207. Chapter 173: *UMOD*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 717 208. Chapter 174: *REN*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 719 209. Chapter 175: *HNF1B*-Related Autosomal Dominant Tubulointerstitial Kidney Disease - p. 721 210. GENETIC CRYSTAL DEPOSITION DISEASES - p. 723 211. Chapter 176: Primary Hyperoxaluria - p. 723 212. Chapter 177: 2,8-Dihydroxyadeninuria - p. 725 213. Chapter 178: Cystinosis - p. 727 214. Chapter 179: Uric Acid Nephropathy/Gout - p. 729 215. GENETIC TRANSPORT DISEASES - p. 733 216. Chapter 180: Bartter Syndrome - p. 733 217. Chapter 181: Dent Disease - p. 735 218. Chapter 182: Oculocerebrorenal Syndrome of Lowe - p. 737 219. OTHER GENETIC DISEASES AFFECTING TUBULES - p. 739 220. Chapter 183: Methylmalonic Acidemia - p. 739 221. Chapter 184: Systemic Karyomegaly - p. 743 222. Chapter 185: Mitochondriopathies - p. 745 223. MISCELLANEOUS TUBULOINTERSTITIAL DISEASES - p. 749 224. Chapter 186: Nephrocalcinosis - p. 749 225. Chapter 187: Secondary Oxalosis - p. 751 226. Chapter 188: Mesoamerican Nephropathy - p. 753 227. Chapter 189: Extramedullary Hematopoiesis - p. 755 228. SECTION 5: INFECTIONS OF KIDNEY - p. 759 229. BACTERIAL INFECTIONS OF KIDNEY - p. 759 230. Chapter 190: Acute Pyelonephritis - p. 759 231. Chapter 191: Chronic Pyelonephritis - p. 769 232. Chapter 192: Xanthogranulomatous Pyelonephritis - p. 773 233. Chapter 193: Malakoplakia - p. 777 234. Chapter 194: Tuberculosis - p. 781 235. Chapter 195: BCG Granulomatous Interstitial Nephritis - p. 783 236. Chapter 196: Leprosy - p. 785 237. Chapter 197: Megalocytic Interstitial Nephritis - p. 786 238. Chapter 198: Nocardiosis - p. 787 239. Chapter 199: Leptospirosis - p. 789 240. Chapter 200: Whipple Disease - p. 791 241. FUNGAL, RICKETTSIAL, AND PARASITIC INFECTIONS OF KIDNEY - p. 793 242. Chapter 201: Mucormycosis - p. 793 243. Chapter 202: Candidiasis - p. 795 244. Chapter 203: Histoplasmosis - p. 796 245. Chapter 204: Coccidioidomycosis - p. 797 246. Chapter 205: Blastomycosis - p. 798 247. Chapter 206: Paracoccidioidomycosis - p. 799 248. Chapter 207: Aspergillosis - p. 800 249. Chapter 208: Cryptococcosis - p. 801 250. Chapter 209: Microsporidiosis - p. 802 251. Chapter 210: Rickettsial Infections - p. 803 252. Chapter 211: Toxoplasmosis - p. 805 253. Chapter 212: Hydatidosis - p. 807 254. VIRAL INFECTIONS OF KIDNEY - p. 809 255. Chapter 213: Polyomavirus Nephritis - p. 809 256. Chapter 214: Cytomegalovirus Infection - p. 817 257. Chapter 215: Adenovirus Infection - p. 819 258. Chapter 216: Epstein-Barr Virus Nephritis - p. 821 259. Chapter 217: Herpes Simplex Acute Nephritis - p. 823 260. Chapter 218: Hantavirus Nephropathy - p. 824 261. SECTION 6: DEVELOPMENTAL DISEASES - p. 825 262. Chapter 219: Overview of Congenital Anomalies of Kidney and Urinary Tract - p. 825 263. Chapter 220: Dysplasia/Hypoplasia/Agenesis - p. 831 264. Chapter 221: Oligomeganephronia - p. 837 265. Chapter 222: Ectopia, Malrotation, Duplication, Fusion, Supernumerary Kidney - p. 839 266. Chapter 223: Ask-Upmark Kidney - p. 843 267. Chapter 224: Renal Tubular Dysgenesis - p. 845 268. SECTION 7: CYSTIC DISEASES - p. 849 269. Chapter 225: Overview of Cystic Diseases - p. 849 270. CILIOPATHIES - p. 857 271. Chapter 226: Autosomal Dominant Polycystic Kidney Disease - p. 857 272. Chapter 227: Autosomal Recessive Polycystic Kidney Disease - p. 863 273. Chapter 228: Nephronophthisis and Related Ciliopathies - p. 869 274. OTHER GENETIC CYSTIC DISEASES - p. 875 275. Chapter 229: von Hippel-Lindau Disease - p. 875 276. Chapter 230: Tuberous Sclerosis Complex - p. 881 277. Chapter 231: Zellweger Syndrome - p. 887 278. MISCELLANEOUS CYSTIC DISEASES - p. 889 279. Chapter 232: Medullary Sponge Kidney - p. 889 280. Chapter 233: Simple and Miscellaneous Cysts - p. 891 281. Chapter 234: Acquired Cystic Disease - p. 893 282. Chapter 235: Mixed Epithelial and Stromal Tumor Family - p. 897 283. Chapter 236: Pediatric Cystic Nephroma - p. 903 284. Chapter 237: Renal Lymphangioma/Lymphangiectasia - p. 907 285. SECTION 8: DISEASES OF COLLECTING SYSTEM - p. 911 286. Chapter 238: Introduction to Impediments to Urine Flow - p. 911 287. Chapter 239: Reflux Nephropathy - p. 917 288. Chapter 240: Obstructive Uropathy - p. 921 289. Chapter 241: Nephrolithiasis - p. 925 290. Chapter 242: Loin Pain Hematuria Syndrome - p. 931 291. SECTION 9: DISEASES OF RENAL ALLOGRAFT - p. 933 292. INTRODUCTION - p. 933 293. Chapter 243: Pathologic Classification of Renal Allograft Diseases - p. 933 294. Chapter 244: Evaluation of Allograft Kidney - p. 937 295. Chapter 245: Evaluation of Donor Kidney - p. 943 296. IMMUNOLOGIC REJECTION - p. 949 297. Chapter 246: Acute T-Cell-Mediated Rejection - p. 949 298. Chapter 247: Chronic T-Cell-Mediated Rejection - p. 961 299. Chapter 248: Hyperacute Rejection - p. 965 300. Chapter 249: Acute Antibody-Mediated Rejection - p. 969 301. Chapter 250: Chronic Antibody-Mediated Rejection - p. 977 302. Chapter 251: Transcript Analysis of Renal Transplant Biopsies - p. 989 303. RECURRENT AND DE NOVO DISEASES - p. 993 304. Chapter 252: Diseases That Recur in Allografts - p. 993 305. Chapter 253: De Novo Focal Segmental Glomerulosclerosis - p. 999 306. Chapter 254: De Novo Membranous Glomerulonephritis - p. 1001 307. Chapter 255: Anti-GBM Disease in Alport Syndrome - p. 1005 308. Chapter 256: Engraftment Syndrome - p. 1007 309. NONIMMUNOLOGIC INJURY - p. 1009 310. Chapter 257: Acute Allograft Ischemia - p. 1009 311. Chapter 258: Hyperperfusion Injury - p. 1013 312. Chapter 259: Urine Leak - p. 1014 313. Chapter 260: Lymphocele - p. 1015 314. Chapter 261: Transplant Renal Artery Stenosis - p. 1016 315. Chapter 262: Renal Artery or Vein Thrombosis - p. 1017 316. Chapter 263: Posttransplant Lymphoproliferative Disease - p. 1019 317. Chapter 264: BK Polyomavirus Neoplasia - p. 1029 318. STABLE AND ACCEPTED GRAFTS - p. 1031 319. Chapter 265: Protocol Biopsies - p. 1031 320. Chapter 266: Accommodation - p. 1035 321. Chapter 267: Tolerance - p. 1037 322. NATIVE KIDNEY PATHOLOGY IN RECIPIENTS OF OTHER TRANSPLANTS - p. 1041 323. Chapter 268: Kidney Diseases in Nonrenal Transplant Recipients - p. 1041 324. Chapter 269: Graft-vs.-Host Glomerulopathies - p. 1045 325. SECTION 10: PROTOCOLS - p. 1047 326. Chapter 270: Kidney Biopsy Reports - p. 1047 327. Chapter 271: Kidney Needle Biopsy - p. 1051 328. Chapter 272: Examination of End-Stage Kidney - p. 1055 329. Chapter 273: Examination of Tumor Nephrectomy Specimens for Nonneoplastic Diseases - p. 1061 330. Chapter 274: Evaluation of Transplant Nephrectomy - p. 1065 331. Chapter 275: Evaluation of Autopsy Kidneys - p. 1069 332. SECTION 11: SPECIALIZED TECHNIQUES - p. 1073 333. Chapter 276: Evaluation of Fibrosis - p. 1073 334. Chapter 277: Immunofluorescence on Paraffin Tissue Sections - p. 1079 335. Chapter 278: Electron Microscopy Processing From Paraffin Tissue - p. 1083 336. Chapter 279: Detection of PLA2R1 Deposits and Autoantibodies - p. 1085 337. Chapter 280: Alport Collagen IV Immunofluorescence - p. 1087 338. Chapter 281: C4d Immunohistochemistry/Immunofluorescence - p. 1089 339. Chapter 282: Polyomavirus Detection in Tissue - p. 1093 340. Chapter 283: Mass Spectrometry - p. 1095 341. Chapter 284: Diagnostic Genetics of Kidney Diseases - p. 1097 342. INDEX - p. 1101
No hay muestra disponible
No hay ficha técnica disponible
